Tools

Lipitor, the popular cholesterol-lowering drug, loses its patent Wednesday, paving the way for cheaper generic versions.

“For generic drugs, they… »   

As cholesterol fighter Lipitor goes generic, its maker Pfizer Inc is hoping to hold onto perhaps a third of the… »   

A study to be published in the online journal mBio® on November 29 shows that adding antibiotics to swine feed… »   

Academic and government leaders announced today the establishment of a major new research institute at The University of Texas MD… »   

Researchers from Mount Sinai School of Medicine, have identified the pattern of cell signaling induced by antipsychotic drugs in a… »   

A low-cost diabetes drug seems to beat the growth of breast cancer, especially by preventing a number of natural and… »   

Biopharmaceutical company Amarin Corp said U.S. health regulators have accepted the marketing application for its heart pill AMR101 and set… »   

Britain is to stop using GlaxoSmithKline’s cervical cancer vaccine Cervarix from next September and will instead offer girls Merck &… »   

Novartis’s costly eye drug Lucentis has been rejected for another new use by Britain’s health cost-effectiveness watchdog NICE, following a… »   

The U.S. Food and Drug Administration has approved a Boston Scientific Corp heart stent, despite concerns about a rare but… »